[
  {"nct_id": "NCT09100001", "drugs": ["retatrutide"], "phase": "Phase 3", "status": "Active, not recruiting", "primary_completion": "2026-09", "title": "Mock TRIUMPH-OB-3 retatrutide in obesity"},
  {"nct_id": "NCT09100002", "drugs": ["orforglipron"], "phase": "Phase 3", "status": "Recruiting", "primary_completion": "2026-12", "title": "Mock ATTAIN-OB-2 orforglipron"},
  {"nct_id": "NCT09100003", "drugs": ["MariTide"], "phase": "Phase 2b", "status": "Active, not recruiting", "primary_completion": "2026-08", "title": "Mock MARITIME-2b MariTide obesity"},
  {"nct_id": "NCT09100004", "drugs": ["survodutide"], "phase": "Phase 3", "status": "Recruiting", "primary_completion": "2027-03", "title": "Mock SYNCHRONIZE-OB-1 survodutide"},
  {"nct_id": "NCT09100005", "drugs": ["tirzepatide"], "phase": "Phase 4", "status": "Recruiting", "primary_completion": "2027-06", "title": "Mock SURMOUNT-RWE tirzepatide"},
  {"nct_id": "NCT09100006", "drugs": ["semaglutide"], "phase": "Phase 4", "status": "Active, not recruiting", "primary_completion": "2026-11", "title": "Mock SELECT-EXT semaglutide"},
  {"nct_id": "NCT09100007", "drugs": ["CagriSema"], "phase": "Phase 3", "status": "Active, not recruiting", "primary_completion": "2026-10", "title": "Mock REDEFINE-1 cagrisema"},
  {"nct_id": "NCT09100008", "drugs": ["amycretin"], "phase": "Phase 1b", "status": "Active, not recruiting", "primary_completion": "2026-07", "title": "Mock amycretin first-in-human extension"},
  {"nct_id": "NCT09100009", "drugs": ["mazdutide"], "phase": "Phase 3", "status": "Recruiting", "primary_completion": "2026-12", "title": "Mock GLORY-1 mazdutide CN obesity"},
  {"nct_id": "NCT09100010", "drugs": ["pemvidutide"], "phase": "Phase 2", "status": "Active, not recruiting", "primary_completion": "2026-09", "title": "Mock IMPACT pemvidutide MASH-obesity"},
  {"nct_id": "NCT09100011", "drugs": ["petrelintide"], "phase": "Phase 1b", "status": "Active, not recruiting", "primary_completion": "2026-08", "title": "Mock petrelintide FIH"},
  {"nct_id": "NCT09100012", "drugs": ["VK2735"], "phase": "Phase 2", "status": "Active, not recruiting", "primary_completion": "2026-09", "title": "Mock VENTURE VK2735 obesity"},
  {"nct_id": "NCT09100013", "drugs": ["danuglipron"], "phase": "Phase 2b", "status": "Active, not recruiting", "primary_completion": "2026-11", "title": "Mock danuglipron ER Phase 2b"},
  {"nct_id": "NCT09100014", "drugs": ["bivamelagon"], "phase": "Phase 2", "status": "Recruiting", "primary_completion": "2026-12", "title": "Mock bivamelagon MC4R obesity"},
  {"nct_id": "NCT09100015", "drugs": ["setmelanotide"], "phase": "Phase 4", "status": "Active, not recruiting", "primary_completion": "2026-12", "title": "Mock setmelanotide registry"},
  {"nct_id": "NCT09100016", "drugs": ["ARD-101"], "phase": "Phase 2", "status": "Recruiting", "primary_completion": "2027-02", "title": "Mock ARD-101 hypothalamic obesity"},
  {"nct_id": "NCT09100017", "drugs": ["GSBR-1290"], "phase": "Phase 2", "status": "Active, not recruiting", "primary_completion": "2026-10", "title": "Mock GSBR-1290 obesity"},
  {"nct_id": "NCT09100018", "drugs": ["HM15211"], "phase": "Phase 2", "status": "Active, not recruiting", "primary_completion": "2026-08", "title": "Mock HM15211 MASH"},
  {"nct_id": "NCT09100019", "drugs": ["ecnoglutide"], "phase": "Phase 2", "status": "Active, not recruiting", "primary_completion": "2026-09", "title": "Mock ecnoglutide Ph2"},
  {"nct_id": "NCT09100020", "drugs": ["liraglutide"], "phase": "Phase 3", "status": "Active, not recruiting", "primary_completion": "2026-07", "title": "Mock liraglutide adolescent"},
  {"nct_id": "NCT09100021", "drugs": ["TERN-601"], "phase": "Phase 1b", "status": "Active, not recruiting", "primary_completion": "2026-07", "title": "Mock TERN-601 FIH"},
  {"nct_id": "NCT09100022", "drugs": ["MET-097i"], "phase": "Phase 1", "status": "Active, not recruiting", "primary_completion": "2026-08", "title": "Mock MET-097i FIH"}
]